Data-driven analyses of clinical trial recruitment and site operations, drawn from referral and call data across the Power network. Readers get specific findings on patient callbacks, screening criteria and site capacity planning.
Website: https://withpower.ghost.io/
PulmCCM covers critical care and pulmonary medicine, with critical appraisals of new trials, regulatory developments, and case-based teaching questions. Readers get detailed breakdowns of study design, results, and limitations, plus CME-oriented learning content.
Junk Charts critiques data visualizations and statistical claims, using frameworks like the Trifecta Checkup to examine charts, data and the questions behind them. Recent issues cover a reproduction of Pfizer Covid-19 vaccine trial analyses, a critique of a subway-stop closure analysis, and a flawed bar chart of top acquisitions.
An oncologist shares lectures and commentary on interpreting cancer clinical trials, including trial design, statistics and conference results. Readers get a critical, clinician's view of how to appraise evidence behind oncology drugs and combinations.
A physician-researcher writes weekly about the science of Parkinson's disease and his own effort to bring a drug candidate (RB-190) into clinical trials. Readers get interpretation of new trial data, personal background, and behind-the-scenes updates on regulatory and drug development work.
One short email a week with hand-picked newsletters from the index. Free, no spam, unsubscribe anytime.
